Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass

Thrombosis Research

Volumn 134, Issue 2, 2014, Pages 360-368

  Kindo, Michel ^a   Hoang Minh, Tam ^a   Gerelli, Sébastien ^a   Perrier, Stéphanie ^a   Meyer, Nicolas ^b   Schaeffer, Mickaël ^b   Bentz, Jonathan ^a   Announe, Tarek ^a   Mommerot, Arnaud ^a   Collange, Olivier ^b   Pottecher, Julien ^b   Cristinar, Mircea ^b   Thiranos, Jean Claude ^b   Gros, Hubert ^b   Mertes, Paul Michel ^b   Billaud, Philippe ^a   Mazzucotelli, Jean Philippe ^a  

^a NHC   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Cardiopulmonary Bypass; Coronary Disease; Fibrinogen; Heart Valve Diseases; Hemostasis Surgical; Postoperative blood loss

Indexed keywords

FIBRINOGEN; HEMOGLOBIN;

AGED; ARTICLE; BLOOD CLOTTING TIME; BODY MASS; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; ADVERSE EFFECTS; BLOOD; BLOOD TRANSFUSION; MIDDLE AGED; PERIOPERATIVE PERIOD; PROGNOSIS;

AGED; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COHORT STUDIES; FEMALE; FIBRINOGEN; HEMOGLOBINS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84905115358     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.05.008     Document Type: Article

References (25)

1. V.A. Ferraris, J.R. Brown, G.J. Despotis, J.W. Hammon, T.B. Reece, and S.P. Saha et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 91 2011 944 982
2. B. Dixon, J.D. Santamaria, D. Reid, M. Collins, T. Rechnitzer, and A.E. Newcomb et al. The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME) Transfusion 53 2013 19 27
3. C.G. Koch, L. Li, A.I. Duncan, T. Mihaljevic, D.M. Cosgrove, and F.D. Loop et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting Crit Care Med 34 2006 1608 1616
4. S.D. Surgenor, G.R. DeFoe, M.P. Fillinger, D.S. Likosky, R.C. Groom, and C. Clark et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure Circulation 114 2006 I43 I48
5. J.H. Levy, R.P. Dutton, J.C. Hemphill III, A. Shander, D. Cooper, and M.J. Paidas et al. Multidisciplinary approach to the challenge of hemostasis Anesth Analg 110 2010 354 361
6. M. Karlsson, L. Ternstrom, M. Hyllner, F. Baghaei, S. Nilsson, and A. Jeppsson Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study Transfusion 48 2008 2152 2158
7. J.H. Levy, F. Szlam, K.A. Tanaka, and R.M. Sniecienski Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding Anesth Analg 114 2012 261 274
8. N. Rahe-Meyer, M. Pichlmaier, A. Haverich, C. Solomon, M. Winterhalter, and S. Piepenbrock et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study Br J Anaesth 102 2009 785 792
9. N. Rahe-Meyer, C. Solomon, A. Hanke, D.S. Schmidt, D. Knoerzer, and G. Hochleitner et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial Anesthesiology 118 2013 40 50
10. C. Solomon, J. Cadamuro, B. Ziegler, H. Schochl, M. Varvenne, and B. Sorensen et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients Transfusion 51 2011 1695 1706
11. B. Sorensen, H.S. Asvaldsdottir, B.R. Gudmundsdottir, and P.T. Onundarson The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery Thromb Res 124 2009 695 700
12. B. Sorensen, M. Tang, O.H. Larsen, P.N. Laursen, C. Fenger-Eriksen, and C.J. Rea The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding Thromb Res 128 Suppl. 1 2011 S13 S16 10.1016/S0049-3848:- X
13. L. Ternstrom, V. Radulovic, M. Karlsson, F. Baghaei, M. Hyllner, and A. Bylock et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study Thromb Res 126 2010 e128 e133
14. H.I. Ucar, M. Oc, M. Tok, O.F. Dogan, B. Oc, and A. Aydin et al. Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery Heart Surg Forum 10 2007 E392 E396
15. C. Solomon, C. Hagl, and N. Rahe-Meyer Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery Br J Anaesth 110 2013 947 956
16. K.A. Tanaka, D. Bolliger, R. Vadlamudi, and A. Nimmo Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma J Cardiothorac Vasc Anesth 26 2012 1083 1093
17. D. Bolliger, F. Szlam, R.J. Molinaro, N. Rahe-Meyer, J.H. Levy, and K.A. Tanaka Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model Br J Anaesth 102 2009 793 799
18. D.R. Spahn, B. Bouillon, V. Cerny, T.J. Coats, J. Duranteau, and E. Fernandez-Mondejar et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline Crit Care 17 2013 R76
19. S.A. Kozek-Langenecker, A. Afshari, P. Albaladejo, C.A. Santullano, R.E. De, and D.C. Filipescu et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology Eur J Anaesthesiol 30 2013 270 382
20. M. Blome, F. Isgro, A.H. Kiessling, J. Skuras, H. Haubelt, and P. Hellstern et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery Thromb Haemost 93 2005 1101 1107
21. B. Sorensen, D.R. Spahn, P. Innerhofer, M. Spannagl, and R. Rossaint Clinical review: Prothrombin complex concentrates-evaluation of safety and thrombogenicity Crit Care 15 2011 201
22. M. Karlsson, L. Ternstrom, M. Hyllner, F. Baghaei, A. Flinck, and S. Skrtic et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study Thromb Haemost 102 2009 137 144
23. C. Fenger-Eriksen, G.W. Moore, S. Rangarajan, J. Ingerslev, and B. Sorensen Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders Transfusion 50 2010 2571 2576
24. S. Ogawa, F. Szlam, D. Bolliger, T. Nishimura, E.P. Chen, and K.A. Tanaka The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry Anesth Analg 115 2012 16 21
25. M. Ranucci, and C. Solomon Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences Br J Anaesth 109 2012 135 137